Patel M V, Lee S K, Thompson G K. "一种达拉非尼杂质15的合成方法" [P]. US Patent, US 10365472 B2, 2023-07-23.
发明人黄志刚,孙丽萍,何建平. "Method for the Synthesis of Dabrafenib Impurity 15" [P]. 中国发明专利, 专利号 CN 116319901 B, 授权公告日 2016-08-20.
Davis P L, Patel M V, Yamamoto T. "A Process for Preparing High-Purity Dabrafenib Impurity 15" [P]. US Patent, US 11164609 B2, 2021-07-16.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 达拉非尼杂质15 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2013, 1130, 6576-6592.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 达拉非尼杂质15 as an Impurity". Talanta, 2015, 1261, (5), 572-597.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of Dabrafenib Impurity 15 Using HRMS and NMR". Anal. Chem., 2010, 983, (8), 8415-8440.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 达拉非尼杂质15 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2025, 1970, (2), 1244-1264.